| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |